Zomedica Corp.
—- Market cap
- —
- Debt
- +$4.36M
- Cash
- −$9.02M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: ZOM stock price vs AEHR: inconclusive — current versus $1.84 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at AEHR's multiple
Implied fair value · at ZOM's multiple
Needs ZOM P/S.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: ZOM FY 2025 (ended Dec 31, 2025) · AEHR FY 2026 (ended May 29, 2026). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Complete market value, debt and cash evidence is required for enterprise value.
Capital structure 99% equity / 1% debt · EV / Revenue 54.49x
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Zomedica Corp. · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
AEHR TEST SYSTEMS · implied price per share
Latest annual free cash flow must be positive to qualify the filing-backed baseline.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.04x
0.12x
Net debt / EBITDA
Leverage against operating earnings
0.06x
10.74x
Cash and equivalents
Liquid reserves on the balance sheet
$9.02M
$116.36M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Zoetis Inc.
ZOM vs ZTS
Elanco Animal Health Inc
ZOM vs ELAN
PHIBRO ANIMAL HEALTH CORP
ZOM vs PAHC
TERADYNE, INC
ZOM vs TER
Merck & Co., Inc.
ZOM vs MRK
LAM RESEARCH CORP
ZOM vs LRCX
APPLIED MATERIALS INC /DE
ZOM vs AMAT
SKYWORKS SOLUTIONS, INC.
ZOM vs SWKS
LATTICE SEMICONDUCTOR CORP
ZOM vs LSCC
$4.36M
$27.15M
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.